Is the whole larger than the sum of the parts? Integrated PET/MRI as a tool for response prediction Felix M. Mottaghy Editorial Commentary 26 December 2017 Pages: 325 - 327
Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy Nariya ChoSeock-Ah ImKoung Jin Suh Original Article 04 November 2017 Pages: 328 - 339
Simultaneous whole-body 18F–PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study Martin T. FreitagClaudia KeschFrederik Giesel Original Article 16 October 2017 Pages: 340 - 347
Prognostic value of 18F–choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide Paola CaroliUgo De GiorgiFederica Matteucci Original Article 06 November 2017 Pages: 348 - 354
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial) Ivan JamborAnna KuismaHeikki Minn Original Article 16 November 2017 Pages: 355 - 364
FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer Pierre LovinfosseMarc PolusRoland Hustinx Original Article 18 October 2017 Pages: 365 - 375
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab Hoda AnwarChristos SachpekidisAntonia Dimitrakopoulou-Strauss Original Article 10 November 2017 Pages: 376 - 383
18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment Pil Soo SungHye Lim ParkSi Hyun Bae Original Article 10 November 2017 Pages: 384 - 391
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma Xavier PalardJulien EdelineEtienne Garin Original Article Open access 25 November 2017 Pages: 392 - 401
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue Jennifer E. GainsNeil J. SebireMark N. Gaze Original Article 17 October 2017 Pages: 402 - 411
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems Andres KaalepTerez SeraRonald Boellaard Original Article Open access 01 December 2017 Pages: 412 - 422
Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson’s disease Han Soo YooSeok Jong ChungPhil Hyu Lee Original Article 26 October 2017 Pages: 423 - 431
Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer’s disease and frontotemporal dementia Young Kyoung JangChul Hyoung LyooSang Won Seo Original Article 16 November 2017 Pages: 432 - 442
Static and dynamic 18F–FET PET for the characterization of gliomas defined by IDH and 1p/19q status Antoine VergerGabriele StoffelsNorbert Galldiks Original Article 17 October 2017 Pages: 443 - 451
Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging Naoki EzawaNagaaki KatohYoshiki Sekijima Original Article 10 September 2017 Pages: 452 - 461
Clinical utility of FDG PET/CT in acute complicated pyelonephritis—results from an observational study Chih-Hsing WanJing-Ren TsengTzu-Chen Yen Original Article 26 September 2017 Pages: 462 - 470
Current status of theranostics in prostate cancer Irene VirgoliniClemens DecristoforoChristian Uprimny Review Article Open access 28 December 2017 Pages: 471 - 495
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review Finn Edler von EybenGiandomenico RovielloTimo Joensuu Review Article Open access 16 December 2017 Pages: 496 - 508
Incidental identification of osteoid osteoma by 68Ga-PSMA PET/CT Angelo CastelloEgesta Lopci Image of the Month 15 December 2017 Pages: 509 - 510
Striking lack of visualization of striatum on 18F-FDG brain PET in chorea-acanthocytosis Diego Alfonso López-MoraValle CamachoIgnasi Carrió Image of the Month 15 December 2017 Pages: 511 - 512
177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial? Kambiz RahbarHojjat AhmadzadehfarMartin Boegemann Letter to the Editor 21 November 2017 Pages: 513 - 514
Reply to ‘Single high dose versus repeated bone-targeted radionuclide therapy’ Ana M. Denis-BacelarSarah J. ChittendenGlenn D. Flux Editorial Commentary 15 December 2017 Pages: 515 - 517